Parmax Pharma Ltd.
BSE: 540359 | Sector: Health care |
NSE: N.A. | ISIN Code: INE240T01014 |
BSE 00:00 | 24 Jun | 29.65 |
1.65 (5.89%) |
OPEN
29.70 |
HIGH
29.70 |
LOW
28.20 |
NSE 05:30 | 01 Jan | Parmax Pharma Ltd |
OPEN | 29.70 |
PREVIOUS CLOSE | 28.00 |
VOLUME | 85 |
52-Week high | 70.90 |
52-Week low | 26.35 |
P/E | 78.03 |
Mkt Cap.(Rs cr) | 11 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Parmax Pharma Ltd. (PARMAXPHARMA) - Nine Monthly Result
Particulars (![]() |
Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 |
Net Sales/Income From Operations | 11.16 | 18.81 | 16.57 | 8.79 | 8.74 |
Other Income | 0.05 | 0.07 | 0.05 | 0.02 | 0.03 |
Total Income | 11.21 | 18.88 | 16.61 | 8.80 | 8.77 |
Total Expenditure | 9.29 | 16.08 | 14.63 | 8.77 | 8.24 |
Operating Profit | 1.92 | 2.80 | 1.98 | 0.03 | 0.53 |
Interest | 0.30 | 0.30 | 0.04 | 0.04 | 0.03 |
Gross Profit | 1.62 | 2.50 | 1.95 | -0.01 | 0.50 |
Depreciation | 1.43 | 1.44 | 0.64 | 0.77 | 0.78 |
PBT | 0.19 | 1.06 | 1.31 | -0.78 | -0.28 |
Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit/(Loss) | 0.19 | 1.06 | 1.31 | -0.78 | -0.28 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 0.19 | 1.06 | 1.31 | -0.78 | -0.28 |
Equity Share Capital | 3.74 | 3.74 | 3.74 | 3.74 | 3.74 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 0.50 | 2.83 | 3.51 | -2.10 | -0.75 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Parmax Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices